Search

everythinglearnresearchcommunity

for

Search:↓

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

A woman's hair loss was probably caused by the antifungal drug anidulafungin.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

A girl developed vitiligo and psoriasis after hepatitis B treatment, and stopping the treatment didn't help.

A hepatitis B patient lost hair in patches after starting and stopping a treatment with pegylated interferon alpha2a.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.